4//SEC Filing
Abbott Matthew S 4
Accession 0001627223-21-000032
CIK 0001627223other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 5:25 PM ET
Size
8.5 KB
Accession
0001627223-21-000032
Insider Transaction Report
Form 4
Abbott Matthew S
VP, CAO & Controller
Transactions
- Exercise/Conversion
Common Stock
2021-05-27$14.43/sh+8,913$128,615→ 42,874.648 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-27−8,913→ 17,824 totalExercise: $14.43From: 2021-03-02Exp: 2030-03-02→ Common Stock (8,913 underlying) - Sale
Common Stock
2021-05-27$35.61/sh−8,913$317,392→ 33,961.648 total
Footnotes (2)
- [F1]Includes directly owned shares, stock units and dividend equivalent units.
- [F2]Shares were sold in multiple transactions at prices ranging from $35.60 to $35.625.
Documents
Issuer
Chemours Co
CIK 0001627223
Entity typeother
Related Parties
1- filerCIK 0001786056
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 5:25 PM ET
- Size
- 8.5 KB